Judge Enjoins FDA From Barring Truthful, Nonmisleading Off-Label Drug Promotion
NEW YORK — A New York federal judge on Aug. 7 ruled that Amarin Pharma Inc. proposes to make “truthful and non-misleading” statements about its prescription fish oil drug and that...To view the full article, register now.
Already a subscriber? Click here to view full article